Nanomedicine current trends in diabetes management

Journal of Nanomedicine and Nanotechnology

Volumn 3, Issue 4, 2012, Pages

  Rahiman, Shaik ^a   Tantry, Bilal Ahmad ^a  

^a JOUF UNIVERSITY   (Saudi Arabia)

Author keywords

Diabetes; Nanomedicine; Nanoparticles; Nanotechnology; Oral insulin

Indexed keywords

EID: 84878074975     PISSN: None     EISSN: 21577439     Source Type: Journal    
DOI: 10.4172/2157-7439.1000137     Document Type: Article

References (90)

1. Aylward GW (2005) Progressive changes in diabetics and their management. Eye (Lond) 19: 1115-1118.
2. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053.
3. Aronson D 2008) Hyperglycemia and pathobiology of diabetic complications. Adv Cardiol 45: 1-16.
4. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H (2003) Role of oxidative stress in atherosclerosis. Am J Cardiol 91: 7-11.
5. Emerich DF, Thanos CG (2003) Nanotechnology and medicine. Expert Opin Biol Ther 3: 655-663.
6. Sahoo SK, Labhasetwar V (2003) Nanotech approaches to drug delivery and imaging. Drug Discov Today 8: 1112-1120.
7. Moghimi SM, Hunter AC, Murray JC (2005) Nanomedicine: current status and future prospects. FASEB J 19: 311-330.
8. Freitas RA Jr (2005) What is nanomedicine? Nanomedicine 1: 2-9.
9. Kroto HW, Heath JR, O'Brien SC, Curl RF, Smalley RE (1985) C60: Buckminste fullerene. Nature 318: 162-163.
10. Pickup JC, Zhi ZL, Khan F, Saxl T, Birch DJ, (2008) Nanomedicine and its potential in diabetes research and practice. Diabetes Metab Res Rev 24: 604-610.
11. Mastrototaro JJ (2000) The MiniMed continuous glucose monitoring system. Diabetes Technol Ther 2: S13-S18.
12. Maran A, Crepaldi C, Tiengo A, Grassi G, Vitali E, et al. (2002) Continuous subcutaneous glucose monitoring in diabetic patients: A multicentre analysis. Diabetes Care 25: 347-352.
13. Garg S, Zisser H, Schwarz S, Bailey T, Kaplan R, et al. (2006) Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care 29: 44-50.
14. McCartney LJ, Pickup JC, Rolinski OJ, Birch DJ (2001) Near-infrared fluorescence lifetime assay for serum glucose based on allophycocyaninlabeled concanavalin A. Anal Biochem 292: 216-221.
15. Ballerstadt R, Schulz JS (2000) A fluorescence affinity hollow fiber sensor for continuous transdermal glucose monitoring. Anal Chem 72: 4185-4192.
16. Hussain F, Birch DJS, Pickup JC (2005) Glucose sensing based on the intrinsic fluorescence of sol-gel immobilized yeast hexokinase. Anal Biochem 339: 137-143.
17. Marvin JS, Hellinga HW (1998) Engineering biosensors by introducing fluorescence allosteric signal transduction: Construction of a novel glucose sensor. J Am Chem Soc 120: 7-11.
18. Tolosa L, Gryczynski I, Eichhorn LR, Dattelbaum JD, Castellano FN, et al. (1999) Glucose sensor for low-cost lifetime-based sensing using a genetically engineered protein. Anal Biochem 267: 114-120.
19. Salins LL, Ware RA, Ensor CM, Daunert S (2001) A novel reagentless sensing system for measuring glucose based on the galactose/glucose-binding protein. Anal Biochem 294: 19-26.
20. Ye K, Schultz JS (2003) Genetic engineering of an allosterically based glucose indicator protein for continuous glucose monitoring by fluorescence resonance energy transfer. Anal Chem 75: 3451-3459.
21. Pickup JC, Hussain F, Evans ND, Rolinski OJ, Birch DJ (2005) Fluorescencebased glucose sensors.Biosens Bioelectron 20: 2555-2565.
22. Ariga K, Hill JP, Ji Q (2007) Layer-by-layer assembly as a versatile bottomup nanofabrication technique for exploratory research and realistic application. Phys Chem Chem Phys 9: 2319-2340.
23. Trau D, Rennenberg R (2003) Encapsulation of glucose oxidase microparticles within a nanoscale layer-by-layer film: immobilization and biosensor applications. Biosens Bioelectron 18: 1491-1499.
24. Chinnayelka S, McShane MJ (2006) Glucose sensors based on microcapsules containing an orange/red competitive binding resonance energy transfer assay. Diabetes Technol Ther 8: 269-278.
25. McShane M, Ritter D (2010) Microcapsules as optical biosensors. J Mater Chem 20: 8189-8193.
26. Zhi ZL, Haynie DT (2006) High-capacity functional protein encapsulation in nanoengineered polypeptide microcapsules. Chem Commun (Camb) 14: 147-149.
27. Zhi ZL, Haynie DT (2006) Straightforward and effective protein encapsulation in polypeptide-based artificial cells. Artif Cells Blood Substit Immobil Biotechnol 34: 189-203.
28. Pickup JC, Zhi ZL, Khan F, Saxl T, Birch DJ (2008) Nanomedicine and its potential in diabetes research and practice. Diabetes Metab Res Rev 24: 604-610.
29. Iijima S (1991) Helical microtubules of graphitic carbon. Nature 354: 56-58.
30. http://nextbigfuture.com/2008/04/microphysiometer-using-multiwall-carbon.html
31. Barone PW, Parker RS, Strano MS (2005) In vivo fluorescence detection of glucose using a single-walled carbon nanotube optical sensor: design, fluorphore properties, advantages, and disadvantages. Anal Chem 77: 7556-7562.
32. Barone PW, Yoon H, Ortiz-Garcia R, Zang J, Ahn JH, et al. (2009) Modulation of single-walled carbon nanotube photoluminescence by hydrogel swelling. ACS Nano 3: 3869-3877.
33. Michalet X, Pinaud FF, Bentolila LA, Tsav JM, Doose S, et al. (2005) Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307: 538-544.
34. Tang B, Cao L, Xu K, Zhuo L, Ge J, et al. (2008) A new biosensor for glucose with high sensitivity and selectivity in serum based on fluorescence resonance energy transfer (FRET) between CdTe quantum dots and Au nanoparticles. Chemistry 14: 3637-3644.
35. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4-14.
36. Carino GP, Mathiowitz E (1999) Oral insulin delivery. Adv Drug Del Rev 35: 249-257.
37. Clore J, ThurbyHay L (2004) Basal insulin therapy. Curr Diab Rep 4: 342-345.
38. Arbit E, Kidron M (2009) Oral insulin: the rationale for this approach and current developments. J Diabetes Sci Technol 3: 562-567.
39. Binder C, Lauritzen T, Faber O, Pramming S (1984) Insulin pharmacokinetics. Diabetes Care 7: 188-199.
40. Feng SS (2008) Nanomedicine: nanoparticles of biodegradable polymers for cancer diagnosis and treatment. COSMOS 4: 185-201.
41. Calceti P, Salmaso S, Walker G, BernkopSchnürch A (2004) Development and in vivo evaluation of an oral insulinPEG delivery system. Eur J Pharm Sci 22: 315-323.
42. ScottMoncrieff JC, Shao Z, Mitra AK (1994) Enhancement of intestinal insulin absorption by bile salt-fatty acid mixed micelles in dogs. J Pharm Sci 83: 1465-1469.
43. Niu M, Lu Y, Hovgaard L, Wu W (2011) Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation. Int J Nanomed 6: 1155-1166.
44. Kotz ́e AF, Lueßen HL, de Leeuw BJ, de Boer AG, Verhoef JC et al. (1998) Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on thepermeability of intestinal epithelial cells (Caco-2). J Control Release 51:35- 46.
45. Lamprecht A, Koenig P, Ubrich N, Maincent P, Neumann D (2006) Low molecular weight heparin nanoparticles: mucoadhesion and behaviour in Caco-2 cells. Nanotechnology 17:3673-3680.
46. Ward PD, Tippin TK and Thakker DR (2000) Enhancing paracellular permeability by modulating epithelial tight junctions. Pharm Sci Technol Today 3:346-358.
47. Ramadas M, Paul W, Dileep K J, Anitha Y, Sharma C P (2000) Lipoinsulin encapsulated alginate-chitosan capsulesIntestinal delivery in diabetic rats. J Microencapsul 17:405-411.
48. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM (2004) Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J Control Release 100:5-28.
49. Hanazaki K, Nose Y, Brunicardi FC (2001) Artificial endocrine pancreas. J Am Coll Surg 193: 310-322.
50. Freitas RA (2005) Current status of Nanomedicine and Medical Nanorobotics. J Comput Theor Nanosci 2: 1-25.
51. Freitas RA Jr (2002) The future of nanofabrication and molecular scale devices in nanomedicine. Stud Health Technol Inform 80:45-59.
52. http://thefutureofthings.com/news/1286/insulin-nanopump-for-accurate-drugdelivery.html.
53. Manish Mishra, Hemant Kumar, Kamlakar Tripathi (2008) Diabetic delayed wound healing and the role of silvernanoparticles. Digest Journal of Nanomaterials and Biostructures 3:49-54.
54. Giugliano D, Ceriello A, Paolisso G (1996) Oxidative stress and diabetic vascular complications. Diabetes Care 19:257-267.
55. Feldman EL, Stevens MJ, Greene DA (1997) Pathogenesis of diabetic neuropathy. Clin Neurosci 4:365-370.
56. Clark RA (1985) Cutaneous tissue repair, basic biologic considerations. I. J Am Acad Dermatol 13: 701-725.
57. Coleman DL (1982) Diabetes-obesity syndromes in mice. Diabetes 31:1-6.
58. Yue DK, McLennan S, Marsh M, Mai YW, Spaliviero J, et al. (1987) Effects of experimental diabetes, uremia, and malnutrition on wound healing. Diabetes 36: 295-299.
59. Silhi N (1988) Diabetes and wound healing. J Wound Care 7:47-51.
60. Warheit DB (2004) Nanoparticles: health impacts? Mater Today 7:32-35.
61. Chung D (2003) Nanoparticles have health benefits too. New Scientist 179: 2410-2416.
62. Zhang F, Chan SW, Spanier JF, Apak F, Jin Q, et al. (2002) Cerium oxide nanoparticles: size-selective formation and structure analysis. Appl Phys Lett 80: 127-129.
63. Perebeinos V, Chan SW, Zhang F (2002) Madelung model prediction for dependence of lattice parameter on nanocrystalsize. Solid State Commun 123: 295-297.
64. Robinson RD, Spanier JE, Zhang F, Chan SW, Herman IP (2002) Visible thermal emission from sub-band-gap laser excited cerium dioxide particles. J Appl Phys 92: 1936.
65. Kilbourn BT (1994) The encyclopedia of advanced materials, Pergamon Press Ltd, Oxford, USA.
66. Kofstad P (1972) Non stoichiometry electrical conductivity in binary metal oxides. Wiley, New York.
67. BT Kilbourn (1986) Encyclopedia of Materials Science and Engineering. Pergamon press Ltd, Oxford, UK.
68. Becker S, Soukup JM, Gallagher JE (2002) Differential particulate air pollution induced oxidant stress in human granulocytes, monocytes and alveolar macrophages. Toxicol In Vitro 16: 209-218.
69. WD Kingery, HK Bowen, DR Uhlman (1976) Introduction to Ceramics. (2ndedn), John Wiley, New York.
70. Wright JB, Lam K, Hanson D, Burrell RE (1999) Efficacy of topical silver against fungal burn wound pathogens. Am J Inf Cont 27: 344-350.
71. Grier N (1983) Silver and its compounds. Disinfection, Sterilization and Preservation. (3rdedn), Lea & Febiger, Philadelphia.
72. Demling RH, DeSanti L (2006) Effects of silver on wound management. Wounds 13: 4.
73. Monafo WW, Moyer CA (1968) The treatment of extensive thermal burns with 0.5% silver nitrate solution. Ann NY Acad Sci 150: 937-945.
74. Fox CL Jr (1968) Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns. Arch Surg 96: 184-188.
75. Yin HQ, Langford R, Burrell RE (1999) Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Bum Care Rehab 20: 195-200.
76. Ruggiero D, Lecomte M, Michoud E, Lagarde M, Wiernsperger N (1997) Involvement of cell-cell interactions in the pathogenesis of diabetic retinopathy. Diabetes Metab 23: 30-42.
77. Guo R, Song Y, Wang G, Murray RW (2005) Does core size matter in the kinetics of ligand exchanges of monolayer-protected Au clusters? J Am Chem Soc 127: 2752-2757.
78. Yakimovich NO, Ezhevskii AA, Guseinov DV, Smirnova LA, Gracheva TA, et al. (2008) Antioxidant properties of gold nanoparticles studied by ESR spectroscopy. Russian Chemical Bulletin 57: 520-523.
79. BarathManiKanth S, Kalishwaralal K, Sriram M, Pandian SR, Youn HS, et al. (2010) Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. J Nanobiotechnology 8: 16.
80. Jain KK (2008) Nanomedicine: application of nanobiotechnology in medical practice. Med Princ Pract 17:89-101.
81. Surendiran A, Sandhiya S, Pradhan SC, Adithan C (2009) Novel applications of nanotechnology in medicine. Indian J Med Res 130: 689-701.
82. Nel A, Xia T, Madler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311: 622-627.
83. Cavaliere-Jaricot S, Darbandi M, Kuçur E, Nann T (2008) Silica coated quantum dots: a new tool for electrochemical and optical glucose detection. Microchim Acta 160: 375-383.
84. Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, et al. (2005) Quantum dots for live cells, in vivo imaging and diagnostics. Science 307: 538-544.
85. Medina C, Santos-Martinez MJ, Radomski A, Corrigan OI, Radomski MW (2007) Nanoparticles pharmacological and toxicological significance. Br J Pharmacol 150: 552-558.
86. Lam CW, James JT, McCluskey R, Hunter RL (2004) Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 77: 126-134.
87. Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, et al. (2006) Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 114: 1172-1178.
88. Oberdorster G, SharpZ, Atudorei V, Elder A, Gelein R, et al. (2004) Translocation of inhaled ultrafine particlesto the brain. Inhal Toxicol 16: 437-445.
89. Radomski A, Jurasz P, onso-Escolano D, Drews M, Morandi M, et al. (2005) Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol 146: 882-893.
90. Chen Z, Meng H, Xing G, Chen C, Zhao Y, et al. (2006) Acute toxicological effects of copper nanoparticles in vivo. Toxicol Lett 163: 109-20.